发明名称 ShKトキシンを含む組成物
摘要 <p>Analogs of ShK toxin and methods for using such ShK analogs. The ShK analogs generally comprise ShK toxin attached to a chemical entity (e.g. an atom, molecule, group, residue, compound, moiety, etc.) that has an anionic charge. In some embodiments the chemical entity attached to the ShK toxin may comprise an amino acid residue. The ShK analogs may be administered to human or non-human animal subjects to cause inhibition of potassium channels or to otherwise treat diseases or disorders. In some embodiments, the chemical entity to which the ShK toxin is attached may be chosen to provide selective inhibition of certain potassium channels (e.g., Kv1.3 channels) over other potassium channels (e.g., Kv1.1 channels). In come embodiments, the chemical entity to which the ShK toxin is attached may include a fluorophore, thereby providing a fluorophore tagged ShK analog. Such fluorophore tagged ShK analogs may be used in flow cytometry alone, or in conjunction with class II tetramers that can detect autoreactive cells.</p>
申请公布号 JP5670961(B2) 申请公布日期 2015.02.18
申请号 JP20120134524 申请日期 2012.06.14
申请人 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニアTHE REGENTS OF THE UNIVERSITY OF CALIFORNIA;バッケム バイオサイエンシズ インコーポレイテッドBACHEM BIOSCIENCES,INC. 发明人 チャンディ、ケイ.ジョージ;ビートン、クリスティン;ペニントン、マイケル ウィリアム
分类号 A61K38/00;A61K47/18;A61K47/42;A61K47/48;A61P1/04;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P5/14;A61P17/00;A61P19/02;A61P19/08;A61P21/00;A61P21/04;A61P25/02;A61P29/00;A61P37/02;A61P37/06;A61P43/00;C07K14/435;G01N33/53;G01N33/533 主分类号 A61K38/00
代理机构 代理人
主权项
地址